NCT06892145View on ClinicalTrials.gov

Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

May 4, 2026

Study Completion Date

February 16, 2028

Conditions
Systemic Lupus Erythematosus (SLE)Refractory
Interventions
BIOLOGICAL

MC-1-50

A single infusion of CD19 CAR-T cells will be administered intravenously after lymphodepletion chemotherapy

Trial Locations (1)

Unknown

The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang

All Listed Sponsors
collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

lead

Chongqing Precision Biotech Co., Ltd

INDUSTRY